Study Confirms Efficacy of Enzyme-Based Advanced Formula ZYMOX Otic Plus

PKB Animal Health, an industry leader in enzyme-based dermatology and oral care products for animals, announced the Polish Journal of Veterinary Sciences has published findings from a recent study on the effects of ZYMOX Otic Plus on canine otitis externa and removal of biofilms. The study evaluated in detail the in vivo and in vitro efficacy and concluded ZYMOX Otic Plus to be effective and beneficial for the management of canine otitis externa.

Canine otitis externa is a common problem affecting a large percentage of dogs and cats, yet antibiotic resistance represents a major challenge to its treatment. While it is believed that bacteria and yeast produce biofilm structures that result in persistent conditions that are not responsive to traditional antibiotic therapeutics, ZYMOX Otic Plus contains a combination of enzymes including the biofilm-degrading enzymes mutanase and dextranase. The results of this study demonstrate the viability of ZYMOX Otic Plus as an alternative to antibiotics.

Additional studies on ZYMOX efficacy have been published in the International Journal of Applied Veterinary Research on antibiofilm efficacy and a broad range of microorganisms, including Pseudomonas aeruginosa,Malassezia, and Methicillin-resistant Staphylococcus aureus (MRSA).

Visit zymox.com to learn more about the Advanced Formula ZYMOX Otic Plus and the full line Dermatology products.